Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation

Glycoconjugate Journal

Volumn 20, Issue 5, 2003, Pages 331-338

  Chatterjee, Subroto ^a   Berliner, Judith A ^b   Subbanagounder, Ganesamoorthy G ^b   Bhunia, Anil K ^a   Koh, Steve ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Galactosyltransferase; Minimally modified low density lipoproteins; Oxidized phospholipids; Proliferation

Indexed keywords

1 PALMITOYL 2 (5 OXOVALEROYL)GLYCERO 4 PHOSPHOCHOLINE; 1 PALMITOYL 2 GLUTARYLGLYCERO 3 PHOSPHOCHOLINE; DEXTRO THREO 1 PHENYL 2 DECANOYLAMINO 3 MORPHOLINO 1 PROPANOL; GALACTOSYLTRANSFERASE; GLUCOSYLCERAMIDE; LACTOSYLCERAMIDE; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PHOSPHORYLCHOLINE; PROPANOL; PROTEIN P44; SUPEROXIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

AORTA; CELL PROLIFERATION; CELLS, CULTURED; GALACTOSYLTRANSFERASES; HUMANS; LIPOPROTEINS, LDL; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; MYOCYTES, SMOOTH MUSCLE; OXIDATION-REDUCTION; PHOSPHOLIPID ETHERS; PHOSPHOLIPIDS; SPHINGOLIPIDS; SUPEROXIDES;

EID: 3543099692     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000033629.54962.68     Document Type: Article

References (32)

1. Hoff HF, Heidman CL, Gaubatz JW, Gotto AM, Jr, Erickson EE, Jackson RL, Apolipoprotein B retention in the grossly normal and atherosclerotic human aorta, Circ Res 40, 56-64 (1977).
2. Henrickson T, Mahoney EM, Steinberg D, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptor for acetylated low density lipoproteins, Proc Natl Acad Sci USA 77, 6499-503 (1981).
3. Steinberg DJ, Low density lipoprotein oxidation and its pathobiological significance [Minireview], J Biol Chem 272, 20963-6 (1977).
4. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, LaDu BN, Faull KF, Fogelman AM, Berliner JA, Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein, J Clin Invest 96, 2882-91 (1995).
5. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA, Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo, J Biol Chem 272, 13597-607 (1997).
6. Berliner J, Leitinger N, Watson A, Huber J, Fogelman A, Navab M, Oxidized lipids in atherogenesis: Formation, destruction and action, Thromb and Hemostatis 78, 195-9 (1997).
7. Chatterjee S, Role of oxidized low density lipoproteins in atherosclerosis, Effects on smooth muscle cell proliferation, Mol Cell Biol 111, 143-7 (1992).
8. Chatterjee S, Ghosh N, Oxidized LDL stimulates aortic smooth muscle cell proliferation, Glycobiology 303-11 (1996).
9. Chatterjee S, Bhunia AK, Snowden A, Han H, Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells, Glycobiology 7, 703-10 (1997).
10. Balagopalakrishna C, Bhunia AK, Rifkind JM, Chatterjee S, Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase, Mol Cell Biochem 170, 85-9 (1997).
11. Ross R, The pathogenesis of atherosclerosis, N Eng J Med 314, 488-500 (1986).
12. Bhunia AK, Han H, Snowden A, Chatterjee S, Redox regulated signaling by lactosylceramide in the proliferation of aortic smooth muscle cells. J Biol Chem 272, 15642-9 (1997).
13. Basu S, Kaufman B, Roseman S, Enzymatic synthesis of ceramide-glucose and ceramide lactose by glycosyltransferase from embryonic chicken brain, J Biol Chem 243, 5802-4 (1968).
14. Basu M, De T, Das KK, Kyle J W, Chon HC, Schaeper RJ, Basu S, Glycosytransferases involved in glycolipid biosynthesis. In Methods in Enzymol edited by Ginsburg V. (Academic Press, New York, 1987), vol. 138 pp. 575-607.
15. Chatterjee S, Castiglione E, Characterization of UDP-Galactose: Glucosylceramide B 1→4: Galactosyltransferase activity in cultured human proximal tubular cells, Biochem Biophys Acta 923, 136-42 (1987).
16. Bhunia AK, Han H, Snowden A, Chatterjee S, Lactosylceramide stimulates Ras GTP loading, kinase (MEK, Raf) p44 mitogen activated protein kinase and c-fos expression in human aortic smooth muscle cell, J Biol Chem 271, 10660-6 (1996).
17. Lowry OH, Rosebrough NJ, Farr AE, Randall RJ, Proteins measurement with the folin phenol reagent, J Biol Chem 193, 265-75 (1951).
18. Ross R, Growth of smooth muscle in culture and formation of elastic fibres, J Cell Biol 50, 172-86 (1971).
19. Chatterjee S, Sphingolipids: In atherosclerosis and vascular biology, Arter Throm and Bascular Biol 18, 1523-33 (1998).
20. Chatterjee S, Oxidized low density lipoprotein and lactosylceramide both stimulate the expression of proliferating nuclear anitgen and the proliferation of aortic smooth muscle cells, Ind J Biochem & Biophys 34, 56-61 (1997).
21. Chatterjee S, Lactosylceramide stimulates aortic smooth muscle cell proliferation, Biochem Biophys Res Comm 181, 554-61 (1991).
22. Lo YY, Cruz TF, Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes, J Biol Chem 270, 11727-30 (1995).
23. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ Res 74, 1141-8 (1994).
24. Jacobson MD, Reactive oxygen species and programmed cell death [Review], Trends Biochem Sci 21, 83-86 (1996).
25. Moncada S, Palmer RM, Higgs EA, Nitric oxide physiology, pathophysiology and pharmacology [Review], Pharm Rev 43, 109-42 (1991).
26. Ohara Y, Petersen TE, Harrison DG, Hypercholesterolemia increases endothelial superoxide anion production, J Clin Invest 91, 2546-51 (1993).
27. Chatterjee S, Dey S, Shi W-Y, Thomas K, Hutchins GM, Accumulation of glycosphingolipids in human atherosclerotic plaque and uneffected aorta tissue, Glycobiology 7, 57-65 (1997).
28. Stadtman ER, Oliver CN, Metal-catalyzed oxidation of proteins. Physiological consequences [Review], J Biol Chem 266, 2005-8 (1991).
29. Schreck R, Rieber P, Baeuerle PA, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J 10, 2247-58 (1991).
30. Stemler KE, Stafforini DM, Prescott SM, McIntyre TM, Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates, J Biol Chem 266, 11095-103 (1991).
31. Arai T, Bhunia AK, Chatterjee S, Bulkley GB, Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro, Circulation Res 82, 540-7 (1998).
32. Subbanagounder G, Leitinger N, Schwenke D, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA, Determinantion of the bioactivity of oxidized phospholipids: Specific oxidized fatty acyl groups at the sn-2 position, Art Thromb Vasc Biol 20, 2248-54 (2000).